Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...
Zacks Investment Research on MSN
Why Acadia (ACAD) is poised to beat earnings estimates again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Holdings Inc. (FTRE) and ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made ...
Stocktwits on MSN
Why did ACAD stock slump 8% after hours today?
CEO Catherine Owen Adams said that the negative trend vote is “disappointing” and “not what we hoped for.” ・The committee ...
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) stock jumped 26.6% to $22.29 on Friday afternoon following a favorable court ruling. What To Know: The U.S. District Court for the District of Delaware upheld ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results